Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Altimmune (ALT) Treasury Shares (2016 - 2025)

Historic Treasury Shares for Altimmune (ALT) over the last 17 years, with Q3 2025 value amounting to $1.1 million.

  • Altimmune's Treasury Shares rose 4484.96% to $1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 million, marking a year-over-year increase of 4484.96%. This contributed to the annual value of $858290.0 for FY2024, which is 4206.17% up from last year.
  • Latest data reveals that Altimmune reported Treasury Shares of $1.1 million as of Q3 2025, which was up 4484.96% from $1.0 million recorded in Q2 2025.
  • Altimmune's Treasury Shares' 5-year high stood at $1.1 million during Q3 2025, with a 5-year trough of $196279.0 in Q1 2021.
  • Over the past 5 years, Altimmune's median Treasury Shares value was $618543.0 (recorded in 2023), while the average stood at $614973.2.
  • In the last 5 years, Altimmune's Treasury Shares crashed by 888.25% in 2021 and then surged by 12765.4% in 2022.
  • Over the past 5 years, Altimmune's Treasury Shares (Quarter) stood at $231928.0 in 2021, then surged by 78.71% to $414485.0 in 2022, then skyrocketed by 45.76% to $604167.0 in 2023, then surged by 42.06% to $858290.0 in 2024, then skyrocketed by 32.35% to $1.1 million in 2025.
  • Its last three reported values are $1.1 million in Q3 2025, $1.0 million for Q2 2025, and $1.1 million during Q1 2025.